Relation between Efficacy of Adalimumab and Pharmacokinetics in Ulcerative colitis.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2017
Price : $35 *
At a glance
- Drugs Adalimumab (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms REAL
- 01 May 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 02 Jun 2014 New trial record